| Risk | Moderately High |
|---|---|
| Min SIP Amount | Not Supported |
| Expense Ratio | 1.54% |
| NAV | ₹10.41 (30 Oct 2020) |
|---|---|
| Fund Started | 19 Feb 2018 |
| Fund Size | ₹99 Cr |
| Name | Sector | Instrument | % Assets |
|---|---|---|---|
| PI Industries Ltd. | Chemicals | Equity | 5.6% |
| Ipca Laboratories Ltd. | Healthcare | Equity | 4.0% |
| Navin Fluorine International Ltd. | Chemicals | Equity | 3.9% |
| Astral Poly Technik Ltd. | Chemicals | Equity | 3.4% |
| SRF Ltd. | Diversified | Equity | 3.4% |
| Ajanta Pharma Ltd. | Healthcare | Equity | 3.0% |
| Crompton Greaves Consumer Electricals Ltd. | Cons Durable | Equity | 2.9% |
| Atul Ltd. | Chemicals | Equity | 2.8% |
| Laurus Labs Ltd. | Healthcare | Equity | 2.7% |
| Reliance Industries Ltd. | Energy | Equity | 2.4% |
BOI AXA Midcap Tax Fund Series 1 Regular Growth is a Equity Mutual Fund Scheme launched by BOI AXA Mutual Fund. This scheme was made available to investors on 19 Feb 2018. Alok Singh is the Current Fund Manager of BOI AXA Midcap Tax Fund Series 1 Regular Growth fund.The fund currently has an Asset Under Management(AUM) of ₹99 Cr and the Latest NAV as of 30 Oct 2020 is ₹10.41.
The BOI AXA Midcap Tax Fund Series 1 Regular Growth is rated Moderately High risk. Minimum SIP Investment is set to 500.
The scheme seeks to generate capital appreciation over a period of ten years by investing predominantly in equity and equity-related securities of midcap companies along with income tax benefit.
Upto Rs. 1.5 lac will be tax free under 80C. Lockin of 3 years. Returns will be taxed at 10%.